XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
25.85
-0.77 (-2.89%)
Jan 6, 2026, 1:29 PM EST - Market open
XOMA Royalty Market Cap
XOMA Royalty has a market cap or net worth of $320.1 million as of January 6, 2026. Its market cap has increased by 0.09% in one year.
Market Cap
320.10M
Enterprise Value
404.93M
1-Year Change
0.09%
Ranking
Category
Stock Price
$25.85
Market Cap Chart
Since December 1, 1998, XOMA Royalty's market cap has increased from $151.40M to $320.10M, an increase of 111.43%. That is a compound annual growth rate of 2.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 329.60M | 0.09% |
| Dec 31, 2025 | 329.30M | 6.36% |
| Dec 31, 2024 | 309.60M | 45.69% |
| Dec 29, 2023 | 212.50M | 0.85% |
| Dec 30, 2022 | 210.70M | -10.64% |
| Dec 31, 2021 | 235.80M | -51.52% |
| Dec 31, 2020 | 486.40M | 103.60% |
| Dec 31, 2019 | 238.90M | 125.16% |
| Dec 31, 2018 | 106.10M | -63.40% |
| Dec 29, 2017 | 289.90M | 1,036.86% |
| Dec 30, 2016 | 25.50M | -83.86% |
| Dec 31, 2015 | 158.00M | -59.01% |
| Dec 31, 2014 | 385.50M | -38.46% |
| Dec 31, 2013 | 626.40M | 220.08% |
| Dec 31, 2012 | 195.70M | 396.70% |
| Dec 30, 2011 | 39.40M | -64.76% |
| Dec 31, 2010 | 111.80M | -19.57% |
| Dec 31, 2009 | 139.00M | 69.31% |
| Dec 31, 2008 | 82.10M | -81.63% |
| Dec 31, 2007 | 447.00M | 100.18% |
| Dec 29, 2006 | 223.30M | 61.69% |
| Dec 30, 2005 | 138.10M | -37.68% |
| Dec 31, 2004 | 221.60M | -59.61% |
| Dec 31, 2003 | 548.60M | 84.40% |
| Dec 31, 2002 | 297.50M | -56.92% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.48B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |